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Background
Anthracycline-based chemotherapy is a conventional
therapy for breast cancer patients, but also negatively
affects host immune function. When the host immune
system does not work, chemotherapy and radiotherapy
cannot kill the cancer cells efficiently. Therefore,
improve the host immune system is important for can-
cer efficient treatment. Meanwhile, natural killer (NK)
cells are well known to boost the immune responses
against cancer.
Methods
In this study, breast cancer cell lines were treated with
anthracycline agent epirubicin (EPI) sequential with
immune cells NK. NK cells in the study were amplified
for 14 days in vitro from autologous adoptive cell trans-
fer of breast cancer patients.
Results
The cytotoxicity of NK cells against breast cancer cells
with 12 hr EPI (5.0 μg/ml) pre-treatment was signifi-
cantly higher than untreated or EPI alone. Thus, EPI
sequential NK cells show the synergistic cytotoxicity
effects against breast cancer cells. Moreover, breast can-
cer cells show increased expression of NKG2D ligands
(ULBP1, ULBP2 and MICA) after treatment of EPI. Addi-
tionally, EPI sequential NK cells secret more IFN-g and
TNF-a as well as the increased expression of perforin
and Granzyme B.
Conclusions
Our findings reveal possible evidence for how to com-
bine anthracycline-based chemotherapy with NK cells
biotherapy to make a better treatment.
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